Skip to search formSkip to main contentSkip to account menu

LY3000328

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzopyransCarbamates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Inhibition of cathepsin S attenuates myocardial ischemia/reperfusion injury by suppressing inflammation and apoptosis
Myocardial ischemia/reperfusion (I/R) injury leads to high mortality and morbidity due to the incomplete understanding of the… 
2014
2014
Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of Abdominal Aortic Aneurysm.
Cathepsin S (Cat S) plays an important role in many pathological conditions, including abdominal aortic aneurysm (AAA… 
2014
2014
Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects.
AIM The aim of this study was to assess the safety and tolerability, pharmacokinetics and pharmacodynamics of LY3000328 when… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)